Table 1.

Response at Weeks 12 and 24

ACR, %Week 12Week 24
BI 695501Adalimumab originatorBI 695501Adalimumab originator
n=321n=318n=321n=318
ACR20*67.061.169.064.5
ACR5029.331.036.836.8
ACR7010.111.113.618.2
DAS28-ESR#, mean change from baseline (95% CI)−2.1−2.0−2.4−2.4
(−2.28, −2.01)(−2.18, −1.91)(−2.51, −2.21)(−2.54, −2.24)
  • *Week 12 risk difference (RD) and 90% CI for BI 695501-adalimumab originator are 5.9% and 90% CI (−0.9%, 12.7%); #Week 24: RD and 95% CI are 4.5% and (−3.4%, 12.5%).